Cargando…
Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders and diabetes. Chaihu Shugan powder (CSP) is a traditional Chinese medicine with a significant therapeutic effect on metabolic diseases, such as NAFLD. However, i...
Autores principales: | Lei, Sisi, Zhao, Shuai, Huang, Xiaoyan, Feng, Yuchao, Li, Zhishang, Chen, Li, Huang, Peiying, Guan, Hansu, Zhang, Haobo, Wu, Qihua, Chen, Bojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512055/ https://www.ncbi.nlm.nih.gov/pubmed/36172180 http://dx.doi.org/10.3389/fphar.2022.967623 |
Ejemplares similares
-
Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
por: Yang, Nan, et al.
Publicado: (2013) -
Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia
por: Wang, Yujiao, et al.
Publicado: (2023) -
A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
por: Gao, Zu, et al.
Publicado: (2022) -
Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway
por: Liang, Yinji, et al.
Publicado: (2018) -
The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials
por: Huang, Peiying, et al.
Publicado: (2022)